Responsible Sharing of Information About Medicines

In order to support the best use of scientific information for patient care, PhRMA, BIO and our member companies have endorsed Principles on Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers. These principles are intended to form the basis for defining new and clear regulatory standards governing responsible, truthful and non-misleading communications to inform health care professionals and payers about the safe and effective use of medicines. The principles pertain primarily to data and information outside of FDA-approved labeling, and are intended to establish responsible, science-based parameters for accurate and trusted sharing.